FDA inspection

Wanbang Biopharmaceuticals: FDA inspection ending Jun 18, 2021

FDA inspection 1145659 · Voluntary Action Indicated (VAI) · Xuzhou

Key facts

Inspection ID 1145659
Firm Wanbang Biopharmaceuticals
FEI number 3007836611
Address No. 6 Yangshan Road, Jinshanqiao Economic Zone
City Xuzhou
Fiscal year 2021
Inspection end date Jun 18, 2021
Classification Voluntary Action Indicated (VAI)
Project area Generic Drug Evaluation
Product type Drugs

At a glance

  • None Citations
  • 1–9 Posted citations
  • No Warning letter followed
  • Yes Form FDA 483 issued
  • No Establishment inspection report (EIR) exists
  • 1–9 Inspections at this FEI

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About FDA inspections

FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.

Source: U.S. Food and Drug Administration (FDA), inspection classification data

Browse all FDA inspections